Zephyr AI

Zephyr AI is a precision medicine company that uses artificial intelligence and large-scale real-world data to support drug discovery, diagnostics, and clinical applications. Its platform applies interpretable machine-learning models to fragmented, multimodal data, turning complex information into actionable insights for research and development. These tools are designed to help partners discover and validate opportunities, make decisions across the therapeutic lifecycle, and move programs toward deployment with greater clarity.

Zephyr AI works with biopharmaceutical and diagnostics companies to tailor its multimodal AI solutions to new drugs and diagnostic programs. The company integrates its technology into partners’ existing research and clinical workflows, without requiring new assays. By connecting population-scale insights with patient-level precision, its solutions aim to help organizations reduce development risk, accelerate progress, and match therapies to patients. Zephyr AI brings together scientists, engineers, clinicians, business leaders, and other innovators around a mission to transform how therapies are developed, delivered, and selected for patients. Its services focus on applying enterprise-scale real-world data and machine learning to advance precision medicine at scale.